124 related articles for article (PubMed ID: 33325322)
1. Partial acquisition of stemness properties in tumorspheres obtained from interleukin-8-treated MCF-7 cells.
Ospina-Muñoz N; Vernot JP
Tumour Biol; 2020 Dec; 42(12):1010428320979438. PubMed ID: 33325322
[TBL] [Abstract][Full Text] [Related]
2. Xanthohumol, a Prenylated Chalcone from Hops, Inhibits the Viability and Stemness of Doxorubicin-Resistant MCF-7/ADR Cells.
Liu M; Yin H; Qian X; Dong J; Qian Z; Miao J
Molecules; 2016 Dec; 22(1):. PubMed ID: 28036030
[TBL] [Abstract][Full Text] [Related]
3. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line.
Ortiz-Montero P; Londoño-Vallejo A; Vernot JP
Cell Commun Signal; 2017 May; 15(1):17. PubMed ID: 28472950
[TBL] [Abstract][Full Text] [Related]
4. Gain-of-function p53 mutant with 21-bp deletion confers susceptibility to multidrug resistance in MCF-7 cells.
Tsou SH; Hou MH; Hsu LC; Chen TM; Chen YH
Int J Mol Med; 2016 Jan; 37(1):233-42. PubMed ID: 26572087
[TBL] [Abstract][Full Text] [Related]
5. Lapatinib enhances the cytotoxic effects of doxorubicin in MCF-7 tumorspheres by inhibiting the drug efflux function of ABC transporters.
Chun SY; Kwon YS; Nam KS; Kim S
Biomed Pharmacother; 2015 May; 72():37-43. PubMed ID: 26054673
[TBL] [Abstract][Full Text] [Related]
6. Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties.
Zhang L; Jiao M; Li L; Wu D; Wu K; Li X; Zhu G; Dang Q; Wang X; Hsieh JT; He D
J Cancer Res Clin Oncol; 2012 Apr; 138(4):675-86. PubMed ID: 22237455
[TBL] [Abstract][Full Text] [Related]
7. Resistance of primary breast cancer cells with enhanced pluripotency and stem cell activity to sex hormonal stimulation and suppression.
Nasr M; Farghaly M; Elsaba T; El-Mokhtar M; Radwan R; Elsabahy M; Abdelkareem A; Fakhry H; Mousa N
Int J Biochem Cell Biol; 2018 Dec; 105():84-93. PubMed ID: 30359767
[TBL] [Abstract][Full Text] [Related]
8. A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer.
Kim do Y; Park EY; Chang E; Kang HG; Koo Y; Lee EJ; Ko JY; Kong HK; Chun KH; Park JH
Oncotarget; 2016 Mar; 7(12):14791-802. PubMed ID: 26895471
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin and α-Mangostin oppositely affect luminal breast cancer cell stemness evaluated by a new retinaldehyde-dependent ALDH assay in MCF-7 tumor spheroids.
Bissoli I; Muscari C
Biomed Pharmacother; 2020 Apr; 124():109927. PubMed ID: 31982725
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic cancer tumorspheres are cancer stem-like cells with increased chemoresistance and reduced metabolic potential.
Domenichini A; Edmands JS; Adamska A; Begicevic RR; Paternoster S; Falasca M
Adv Biol Regul; 2019 May; 72():63-77. PubMed ID: 30853342
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer.
Yue D; Zhang Z; Li J; Chen X; Ping Y; Liu S; Shi X; Li L; Wang L; Huang L; Zhang B; Sun Y; Zhang Y
Exp Cell Res; 2015 Aug; 336(1):141-9. PubMed ID: 26096658
[TBL] [Abstract][Full Text] [Related]
12. Mithramycin A sensitizes therapy-resistant breast cancer stem cells toward genotoxic drug doxorubicin.
Saha S; Mukherjee S; Mazumdar M; Manna A; Khan P; Adhikary A; Kajal K; Jana D; Sa G; Mukherjee S; Sarkar DK; Das T
Transl Res; 2015 May; 165(5):558-77. PubMed ID: 25468484
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cell generation during epithelial-mesenchymal transition is temporally gated by intrinsic circadian clocks.
De A; Beligala DH; Sharma VP; Burgos CA; Lee AM; Geusz ME
Clin Exp Metastasis; 2020 Oct; 37(5):617-635. PubMed ID: 32816185
[TBL] [Abstract][Full Text] [Related]
14. Lapatinib sensitizes quiescent MDA-MB-231 breast cancer cells to doxorubicin by inhibiting the expression of multidrug resistance-associated protein-1.
Kwon YS; Chun SY; Nam KS; Kim S
Oncol Rep; 2015 Aug; 34(2):884-90. PubMed ID: 26063481
[TBL] [Abstract][Full Text] [Related]
15. Preliminary study of the effects of β-elemene on MCF-7/ADM breast cancer stem cells.
Dong Y; Li L; Wang L; Zhou T; Liu JW; Gao YJ
Genet Mol Res; 2015 Mar; 14(1):2347-55. PubMed ID: 25867381
[TBL] [Abstract][Full Text] [Related]
16. Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer.
Zhang L; Xu L; Zhang F; Vlashi E
Cell Cycle; 2017 Apr; 16(8):737-745. PubMed ID: 27753527
[TBL] [Abstract][Full Text] [Related]
17. A High-Throughput Image Cytometry Method for the Formation, Morphometric, and Viability Analysis of Drug-Treated Mammospheres.
Kessel SL; Chan LL
SLAS Discov; 2020 Aug; 25(7):723-733. PubMed ID: 32396489
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase (HDAC) inhibitors and doxorubicin combinations target both breast cancer stem cells and non-stem breast cancer cells simultaneously.
Hii LW; Chung FF; Soo JS; Tan BS; Mai CW; Leong CO
Breast Cancer Res Treat; 2020 Feb; 179(3):615-629. PubMed ID: 31784862
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of hedgehog signaling depresses self-renewal of pancreatic cancer stem cells and reverses chemoresistance.
Huang FT; Zhuan-Sun YX; Zhuang YY; Wei SL; Tang J; Chen WB; Zhang SN
Int J Oncol; 2012 Nov; 41(5):1707-14. PubMed ID: 22923052
[TBL] [Abstract][Full Text] [Related]
20. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.
Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ
Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]